Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan
Methotrexate vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Methotrexate and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan β Antibody.